Loading…
Loading…
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In HCA To Contact Him Directly To Discuss Their Options If you purchased or acquired stock in HCA and would like to discuss your legal rights, contact Bragar Eagel & Squire partners Brandon Walker or Melissa Fortunato by email at investigations@bespc.com or by telephone at (212) 355-4648.
NEW YORK, July 21, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of HCA Healthcare, Inc. (“HCA” or the “Company”) (NYSE: HCA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
RADNOR, Pa., July 21, 2026 (GLOBE NEWSWIRE) -- Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, is investigating potential violations of the federal securities laws by HCA Healthcare, Inc. (NYSE: HCA) on behalf of investors who purchased or acquired HCA Healthcare, Inc. securities and experienced significant financial losses.
NEW YORK, July 20, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against HCA Healthcare, Inc. (“HCA Healthcare” or the “Company”) (NYSE: HCA). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices.
RADNOR, Pa.--(BUSINESS WIRE)-- #classaction--Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, is investigating potential violations of the federal securities laws by HCA Healthcare, Inc. (NYSE: HCA) on behalf of investors who purchased or acquired HCA Healthcare, Inc. securities and experienced significant financial losses.HCA Announces Disappointing Financial ResultsOn July 14, 2026, HCA issued a press release reporting its preliminary financial an.
HCA faces Q2 earnings uncertainty as rising expenses and fewer outpatient surgeries may offset admission growth.
LOS ANGELES--(BUSINESS WIRE)---- $HCA--HCA Investors Have Opportunity to Join HCA Healthcare, Inc. Fraud Investigation with the Schall Law Firm.
NEW YORK, July 16, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of HCA Healthcare, Inc. ("HCA" or the "Company") (NYSE: HCA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
Full call transcripts — prepared remarks + analyst Q&A — with speaker-by-speaker formatting and one-click switching across every quarter on file.
Click below to see what's inside, then upgrade to read every transcript for HCA and 80,000+ other tickers.
Transcripts source: company-published earnings calls. Speaker attribution and formatting are processed in-app.